肺癌是我国及世界范围内发病率和死亡率最高的恶性肿瘤之一，非小细胞肺癌（NSCLC）约占肺癌的 85%，1/3 的患者在确诊时已为局部晚期 NSCLC，5 年生存率仅 13% ~ 16%。其中，N2 期肺癌患者预后更差，手术切除后 3 年生存率仅 9% ...

Among patients with non-small cell lung cancer treated with resection surgery, those classified as stage I vs. stage III had ...

Clinical care changes that ended racial disparities in early-stage breast and lung cancer also boosted outcomes for all ...

During a live event, participating oncologists discuss the role of ctDNA and molecular testing in muscle-invasive bladder ...

Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for ...

Recent research published in The Lancet Respiratory Medicine confirms that emphysema was detected in 24% to 31% of patients undergoing lung cancer screening. This means that for millions of Americans, ...

A surgeon mistakenly removed the wrong part of a cancer patient’s lung ... and that the lung had rotated. He assessed the orientation of the lung at every stage of the procedure through a ...

In addition to the coverage in NSCLC, Signatera is also covered by Medicare for adjuvant and recurrence monitoring in colorectal cancer, muscle-invasive bladder cancer, breast cancer, and ovarian ...